EZZ Life Science Holdings Ltd (ASX: EZZ) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

EZZ Life Science Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $183.02 million
P/E Ratio 24.98
Dividend Yield 0.62%
Shares Outstanding 44.42 million
Earnings per share 0.081
Dividend per share 0.03
Year To Date Return 357.69%
Earnings Yield 4.00%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • EZZ Life Science Holdings Ltd (ASX: EZZ)
    Latest News

    A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
    Healthcare Shares

    Up 630% this year AND profitable! This small ASX healthcare share is glowing

    Why has this stock delivered incredible returns this year? Let's find out.

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    16 May 2024 $0.0150 100.00% Interim 17 Jun 2024
    30 Oct 2023 $0.0100 100.00% Final 08 Dec 2023
    22 May 2023 $0.0098 100.00% Interim 23 Jun 2023
    03 Nov 2022 $0.0045 100.00% Final 16 Dec 2022
    09 Nov 2021 $0.0045 100.00% Final 16 Dec 2021

    EZZ ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About EZZ Life Science Holdings Ltd

    EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity,human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

    EZZ Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    11 Oct 2024 $4.12 $-0.34 -7.62% 148,440 $4.45 $4.45 $4.05
    10 Oct 2024 $4.46 $0.16 3.72% 87,919 $4.30 $4.55 $4.25
    09 Oct 2024 $4.30 $-0.09 -2.05% 191,389 $4.39 $4.55 $4.18
    08 Oct 2024 $4.39 $-0.24 -5.18% 126,584 $4.63 $4.63 $4.31
    07 Oct 2024 $4.63 $-0.33 -6.65% 162,834 $4.91 $4.91 $4.50
    04 Oct 2024 $4.96 $0.53 11.96% 198,088 $4.47 $4.97 $4.47
    03 Oct 2024 $4.43 $-0.12 -2.64% 193,969 $4.60 $4.60 $4.30
    02 Oct 2024 $4.55 $0.03 0.66% 95,274 $4.46 $4.75 $4.42
    01 Oct 2024 $4.52 $-0.01 -0.22% 154,289 $4.64 $4.64 $4.30
    30 Sep 2024 $4.53 $0.49 12.13% 563,579 $4.24 $4.74 $4.24
    27 Sep 2024 $4.04 $0.28 7.45% 420,984 $3.85 $4.29 $3.85
    26 Sep 2024 $3.76 $0.24 6.82% 122,524 $3.60 $3.87 $3.60
    25 Sep 2024 $3.52 $-0.05 -1.40% 148,933 $3.58 $3.82 $3.46
    24 Sep 2024 $3.57 $0.37 11.56% 353,181 $3.20 $3.59 $3.14
    23 Sep 2024 $3.20 $0.30 10.34% 147,398 $2.93 $3.20 $2.87
    20 Sep 2024 $2.90 $-0.22 -7.05% 285,372 $3.07 $3.17 $2.86
    19 Sep 2024 $3.12 $0.04 1.30% 56,140 $3.20 $3.20 $2.95
    18 Sep 2024 $3.08 $-0.02 -0.65% 155,804 $3.10 $3.25 $3.03
    17 Sep 2024 $3.10 $0.04 1.31% 85,014 $3.01 $3.10 $2.95
    16 Sep 2024 $3.06 $0.24 8.51% 211,728 $2.89 $3.12 $2.89
    13 Sep 2024 $2.82 $-0.32 -10.19% 273,568 $3.19 $3.19 $2.71
    12 Sep 2024 $3.14 $0.13 4.32% 145,915 $3.09 $3.22 $3.05

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    21 Aug 2024 Ivan Oshry Issued 15,000 $1,200
    Issued under employee share plan.
    21 Aug 2024 Lily (Hao) Huang Issued 15,000 $1,200
    Issued under employee share plan.
    21 Aug 2024 Glenn Cross Issued 15,000 $1,200
    Issued under employee share plan.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Ivan Oshry Non-Executive Director Oct 2020
    Mr Oshry has more than 30 years of experience of legal practice in Australia and internationally, specializing in commercial and corporate law. Mr Oshry was formerly a senior partner at Fluxmans Attorneys in Johannesburg and headed up the corporate department at Kemp Strang (which was merged with Thomson Geer) in Sydney. He is also Chair of Risk Committee and Human Resources Committee.
    Ms Lily (Hao) Huang Non-Executive Director Oct 2020
    Ms Huang has over 20 years of experience in the wealth management and banking industry. She has been working with Citi Group Australia since 2017 as Vice President of the APAC Desk of the Investment Partnerships Division. She is Chair of Human Resources and Risk Committee.
    Mr Mark (Qizhou) Qin Chief Operating OfficerExecutive DirectorInterim Chief Executive Officer Sep 2018
    Mr Qin has a background in management consulting and experience in sales and marketing. Mr Qin also authored five books in sales and marketing for the consumer health industry between 2003 and 2008.
    Mr Glenn Walter Cross Non-Executive ChairmanNon-Executive Director Dec 2021
    Mr Cross has 40 years of experience in life science sector domestically and internationally, including over 20 years in a senior executive capacity. He was formerly CEO and COO of AusBiotech over a period spanning 13 years. He is member of the Risk Committee and Human Resources Committee.
    Ms Natalie Sylvia Climo Company Secretary
    -
    Anthony Guarna Chief Financial Officer
    -
    Natalie Sylvia Climo Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Macquarie Holdings Pty Ltd 17,016,000 39.85%
    JNJ Mok Pty Ltd 11,344,000 26.56%
    Dr Mohammed Nabil Mohammed Eltokhy 557,091 1.32%
    Dr Mohammed Nabil Mohammed Eltokhy & Mrs Rana Farouk Mohamed <Mnt Super A/C> 500,000 1.17%
    Rana Farouk Mohamed <Mnt Super A/C> 486,000 1.14%
    Miss Jing Chen 480,000 1.12%
    Mr Haitao Zheng 480,000 1.12%
    Mars Family Investment Pty Ltd <Mars Family A/C> 480,000 1.12%
    BNP Paribas Nominees Pty Ltd < IB AU Noms Retail Client Drp> 421,358 0.99%
    Ms Xiaojing Wang 150,000 0.35%
    Mr Ying Chuang Wang 147,005 0.34%
    Stephen Anthony Mander 120,040 0.28%
    Merrill Lynch (Australia) Nominees Pty Limited 116,060 0.27%
    Bai Nominees Pty Ltd <Bai Superannuation Fund A/C> 108,972 0.26%
    D & T Superannuation Pty Ltd <Suntan Super Fund A/C> 100,000 0.23%
    Peter Cowen Pty Ltd <Peter Cowen Super Fund A/C> 100,000 0.23%
    Ms Dandan Li 100,000 0.23%
    Mrs Li Zhu <Knight Holding Fund A/C> 95,229 0.22%
    Mr Xianfeng Gao & Ms Yang Sun 87,887 0.21%
    Wang Brothers Pty Ltd <Wang Brothers Family A/C> 81,135 0.19%

    Profile

    since

    Note